Clinical Trial Update: A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of a single application of an 8% capsaicin transdermal patch versus placebo in reducing pain intensity in painf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Capsaicin 8% Transdermal Delivery System (capsaicin 8% patch)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Diabetic Peripheral Neuropathy, Pain | Phase 3 | Status: COMPLETED | Results posted: 2015-03-13